Related references
Note: Only part of the references are listed.Interleukin 6 trans-signalling and risk of future cardiovascular events
Louise Ziegler et al.
CARDIOVASCULAR RESEARCH (2019)
All roads lead to IL-6: A central hub of cardiometabolic signaling
Peter Libby et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction
Hilde E. Groot et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial+
Ola Kleveland et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction
Sean van Diepen et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Circulating Levels of IL-6 Receptor and gp 130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
Vibeke N. Ritschel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
The varying faces of IL-6: From cardiac protection to cardiac failure
Jillian A. Fontes et al.
CYTOKINE (2015)
Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes The GIPS-III Randomized Clinical Trial
Chris P. H. Lexis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The inflammatory response in myocardial injury, repair, and remodelling
Nikolaos G. Frangogiannis
NATURE REVIEWS CARDIOLOGY (2014)
Secretory Phospholipase A2-IIA and Cardiovascular Disease
Michael V. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study
Payman Zamani et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
Chris P. H. Lexis et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
The interleukin-6 pathway and atherosclerosis
S. Matthijs Boekholdt et al.
LANCET (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Healthy aging and disease: role for telomere biology?
Haidong Zhu et al.
CLINICAL SCIENCE (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction
Karol A. Kaminski et al.
ATHEROSCLEROSIS (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes - Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)
Victor J. Dzau et al.
CIRCULATION (2006)
Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation
M Puhakka et al.
JOURNAL OF CARDIAC FAILURE (2003)
Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade
JPS Henriques et al.
CIRCULATION (2003)
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
JS Yudkin et al.
ATHEROSCLEROSIS (2000)
Share Paper
